Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · Patients with osteoarthritis of the knee or hip
Oral or transdermal opioids showed no clear difference in pain intensity Various pain scales. (median compared with placebo (high certainty).
1 finding from 1 review
Function Various validated function scales. · Patients with osteoarthritis of the knee or hip
Oral or transdermal opioids showed no clear difference in function Various validated function scales. (median compared with placebo (high certainty).
1 finding from 1 review
Adverse events as N of participants with at least one adverse event objective · Patients with osteoarthritis of the knee or hip
Oral or transdermal opioids probably leads to higher number of participants experiencing any adverse event (median compared with placebo (moderate certainty).
1 finding from 1 review
Number of patients who withdrew because of adverse events · Patients with osteoarthritis of the knee or hip
Oral or transdermal opioids leads to higher number of participants who withdrew because of adverse events (median compared with placebo (high certainty).
1 finding from 1 review
Number of participants experiencing any serious adverse events · Patients with osteoarthritis of the knee or hip
Oral or transdermal opioids showed no clear difference in number of participants experiencing any serious adverse event (median compared with placebo (low certainty).
1 finding from 1 review
Withdrawal symptoms · Patients with osteoarthritis of the knee or hip
Oral or transdermal opioids probably leads to higher withdrawal symptoms (median compared with placebo (moderate certainty).
1 finding from 1 review
Outcomesa · patients with osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Pain · patients with osteoarthritis
1 finding from 1 review
Physical function · patients with osteoarthritis
Tramadol alone probably leads to higher physical function compared with other opioids (moderate certainty).
1 finding from 1 review
Number of participants reporting an adverse event · patients with osteoarthritis
It is very uncertain whether tramadol alone changes number of participants experiencing any adverse event compared with other opioids (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with osteoarthritis
Tramadol alone may leads to higher number of participants who withdrew due to adverse events compared with other opioids (low certainty).
1 finding from 1 review
Number of participants experiencing any serious adverse events · patients with osteoarthritis
It is very uncertain whether tramadol alone changes number of participants experiencing any serious adverse events compared with other opioids (very low certainty).
1 finding from 1 review
Outcomesa · patients with osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Pain · patients with osteoarthritis
1 finding from 1 review
Physical function · patients with osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Number of participants reporting an adverse event · patients with osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · patients with osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Number of participants experiencing any serious adverse events · patients with osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review